Background & Sources: Recovery and management of Progressive Multifocal Leukoencephalopathy linked to Tysabri

This page collects vetted references on medical safety, regulatory guidance, and clinical background for anyone researching this topic.

Featured analysis

Understanding Recovery and management of Progressive Multifocal Leukoencephalopathy linked to Tysabri — detailed background and analysis.

U.S. Food and Drug Administration (FDA)

Reference: U.S. Food and Drug Administration (FDA)

Authoritative source for clinical, regulatory, and public-health background reading.

ClinicalTrials.gov

Reference: ClinicalTrials.gov

Authoritative source for clinical, regulatory, and public-health background reading.